GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced today the launch of a secondary underwritten public offering of 13,281,302 shares of its common stock (the “GEHC Shares”). The company is not selling any shares and will not receive any proceeds from this offering.
As part of the transaction, GE Aerospace, a division of General Electric, is expected to exchange the GEHC Shares for outstanding debt owed to Morgan Stanley Bank, N.A. (the “MS Lender”), an affiliate of Morgan Stanley & Co. LLC, the selling stockholder in this offering. Following this debt-for-equity exchange, Morgan Stanley & Co. LLC intends to sell the shares to underwriters in the offering.
J.P. Morgan, Citigroup, and Morgan Stanley are serving as the lead joint book-running managers for the offering.
The company has filed an automatically effective shelf registration statement with the U.S. Securities and Exchange Commission (SEC) for the offering. Investors are encouraged to read the prospectus and related documents available on the SEC’s website (www.sec.gov) or by contacting the underwriters for more information.
This release does not constitute an offer to sell or solicit offers to buy securities in any jurisdiction where such offers would be unlawful.
About GE HealthCare Technologies Inc.
GE HealthCare is a global leader in medical technology, pharmaceutical diagnostics, and digital solutions, committed to enhancing healthcare outcomes through integrated services and data analytics. With over 125 years of experience, GE HealthCare is focused on advancing personalized, connected care to improve patient health and clinical outcomes. The company operates across Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, with approximately 51,000 employees worldwide.
